Ni-Fe2O4 Nanoparticles as Contrast Agents for Magnetic Resonance Imaging

被引:33
作者
Ahmad, Tanveer [1 ]
Rhee, Ilsu [1 ]
Hong, Sungwook [2 ]
Chang, Yongmin [3 ]
Lee, Jaejun [3 ]
机构
[1] Kyungpook Natl Univ, Sch Phys & Energy Sci, Taegu 702701, South Korea
[2] Daegu Univ, Div Sci Educ, Gyongsan 712714, South Korea
[3] Kyungpook Natl Univ & Hosp, Coll Med, Dept Diagnost Radiol, Taegu 700721, South Korea
关键词
Ni-Fe2O4; Nanoparticles; Contrast Agent for MRI; T-1 and T-2 Relaxivities; IRON-OXIDE NANOPARTICLES; IN-VIVO; MRI; BIOCOMPATIBILITY; DELIVERY; CHITOSAN;
D O I
10.1166/jnn.2011.4502
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Reported herein is the synthesis of a dextran coating on nickel ferrite (Ni-Fe2O4) nanoparticles via chemical coprecipitation. The aqueous solution of the synthesized nanoparticles showed good colloidal stability, and no precipitate was observed 20 months after the synthesis. The coated nanoparticles were found to be cylindrical in shape in the TEM images, and showed a uniform size distribution with an average length and diameter of 17 and 4 nm, respectively. The coated particles were evaluated as potential T-1 and T-2 contrast agents for MRI. The T-1 and T-2 relaxations of the hydrogen protons in the water molecules in an aqueous solution of dextran-coated Ni-Fe2O4 nanoparticles were studied. It was found that the T-1 relaxivity for the aqueous solution of dextran-coated nanoparticles was slightly greater than that of a commercial Gd-DTPA-BMA contrast agent. The T-2 relaxivity, however, was almost twice that of the commercial Gd-DTPA-BMA contrast agent. Animal experimentation also demonstrated that the dextran-coated Ni-Fe2O4 nanoparticles are suitable for use as either T-1 or T-2 contrast agents in MRI.
引用
收藏
页码:5645 / 5650
页数:6
相关论文
共 32 条
[1]   Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI [J].
Amirbekian, Vardan ;
Lipinski, Michael J. ;
Briley-Saebo, Karen C. ;
Amirbekian, Smbat ;
Aguinaldo, Juan Gilberto S. ;
Weinreb, David B. ;
Vucic, Esad ;
Frias, Juan C. ;
Hyafil, Fabien ;
Mani, Venkatesh ;
Fisher, Edward A. ;
Fayad, Zahi A. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (03) :961-966
[2]  
[Anonymous], 1980, Infrared Characteristic Group Frequencies
[3]  
Arias I.M., 2001, The Liver Biology and Pathobiology, V4th
[4]   Cell internalization of anionic maghemite nanoparticles: Quantitative effect on magnetic resonance imaging [J].
Billotey, C ;
Wilhelm, C ;
Devaud, M ;
Bacri, JC ;
Bittoun, J ;
Gazeau, F .
MAGNETIC RESONANCE IN MEDICINE, 2003, 49 (04) :646-654
[5]  
Bracher E., 2001, CHEM CONTRAST AGENTS
[6]   Iron oxide MR contrast agents for molecular and cellular imaging [J].
Bulte, JWM ;
Kraitchman, DL .
NMR IN BIOMEDICINE, 2004, 17 (07) :484-499
[7]   Flame Synthesis and In Vitro Biocompatibility Assessment of Superparamagnetic Iron Oxide Nanoparticles: Cellular Uptake, Toxicity and Proliferation Studies [J].
Buyukhatipoglu, K. ;
Miller, T. A. ;
Clyne, A. Morss .
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2009, 9 (12) :6834-6843
[8]  
Chapon C., 2003, Investigative Radiology, V38, P141, DOI 10.1097/00004424-200303000-00001
[9]   Gold-coated iron nanoparticles:: a novel magnetic resonance agent for T1 and T2 weighted imaging [J].
Cho, SJ ;
Jarrett, BR ;
Louie, AY ;
Kauzlarich, SM .
NANOTECHNOLOGY, 2006, 17 (03) :640-644
[10]   Targeted nanoparticle-based drug delivery and diagnosis [J].
Emerich, Dwaine F. ;
Thanos, Christopher G. .
JOURNAL OF DRUG TARGETING, 2007, 15 (03) :163-183